CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
in patients ≥ 6 to < 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations a...
Phase 3
Barcelona, Spain and 80 other locations
This study will assess the effects of benralizumab on airway dynamics in severe eosinophilic asthma in terms of quantitative computed tomogr...
Phase 4
Barcelona, Spain and 33 other locations
This is a study designed to evaluate efficacy and safety of Tezepelumab in reducing oral corticosteroid use in adult patients with severe asthma...
Phase 3
Barcelona, Spain and 76 other locations
12 years old with moderate to severe asthma....
Phase 2
Barcelona, Catalunya, Spain and 19 other locations
Primary Objective:To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a pre...
Phase 3
Barcelona, Barcelona [Barcelona], Spain and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Barcelona, Spain and 97 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.The study duration will be up to 37 weeks including an investigati...
Phase 3
Barcelona, Catalunya, Spain and 45 other locations
This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma...
Phase 3
Barcelona, Spain and 141 other locations
BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma...
Phase 2
Barcelona, Spain and 132 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Barcelona, Spain and 95 other locations
Clinical trials
Research sites
Resources
Legal